Epidermal innervation in type 1 diabetic patients: a 2.5-year prospective study after simultaneous pancreas/kidney transplantation
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
18443196
PubMed Central
PMC2494625
DOI
10.2337/dc07-2409
PII: dc07-2409
Knihovny.cz E-zdroje
- MeSH
- diabetes mellitus 1. typu krev patologie patofyziologie chirurgie MeSH
- diabetické nefropatie krev patologie chirurgie MeSH
- diabetické neuropatie patologie MeSH
- dospělí MeSH
- jehlová biopsie MeSH
- krevní glukóza metabolismus MeSH
- kůže inervace patologie MeSH
- lidé MeSH
- následné studie MeSH
- nervová vlákna fyziologie MeSH
- percepce MeSH
- prospektivní studie MeSH
- referenční hodnoty MeSH
- transplantace ledvin * MeSH
- transplantace slinivky břišní * MeSH
- vibrace MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- krevní glukóza MeSH
OBJECTIVE: To assess the effect of normoglycemia following simultaneous pancreas/kidney transplantation (SPK) on neurological function and intraepidermal nerve fiber density (IENFD) in patients with type 1 diabetes. RESEARCH DESIGN AND METHODS: We performed vibration perception threshold (VPT) testing and autonomic function testing (AFT) and assessed IENFD in skin biopsies from the lower thigh and upper calf in 14 healthy control subjects and 18 patients with type 1 diabetes at the time of and at 21-40 (median 29) months post SPK. RESULTS: At baseline, significantly increased VPTs, pathological AFT results, and severe reduction in IENFD were present in SPK recipients. After SPK, an increase of IENFD in the thigh of more than one epidermal nerve fiber per millimeter was noted in three patients (median 4.1, range 1.9-10.2), but changes were not significant for the group as a whole. CONCLUSIONS: We conclude that either irreversible nerve damage might be present in some SPK recipients or that longer periods of normoglycemia might be needed to allow nerve regeneration.
Zobrazit více v PubMed
Boulton AJM, Malik RA, Arezzo JC, et al.: Diabetic somatic neuropathies. Diabetes Care 27:1458–1486, 2004 PubMed
Navarro X, Sutherland DER, Kennedy WR: Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol 42:727–736, 1997 PubMed
Kennedy WR, Wendelschafer-Crabb G, Johnson T: Quantitation of epidermal nerves in diabetic neuropathy. Neurology 47:1042–1048, 1996 PubMed
Boucek P, Havrdova T, Voska L, et al.: Severe depletion of intraepidermal nerve fibres in skin biopsies of pancreas transplant recipients. Transplant Proc 37:3574–3575, 2005 PubMed
Kennedy WR, Wendelschafer-Crabb G, Polydefkis M, et al.: Pathology and quantitation of cutaneous nerves. In Peripheral Neuropathy, 4th ed. Dyck PJ, Thomas PK, Eds. Philadelphia, Saunders, 2005, p. 869–896
Howorka K, Pumprla J, Schabmann A: Optimal parameters of short-term heart rate spectrogram for routine evaluation of diabetic cardiovascular autonomic neuropathy. J Auton Nerv Syst 69:164–172, 1998 PubMed
Del Carro U, Fiorina P, Amadio S, et al.: Evaluation of polyneuropathy markers in type 1 diabetic kidney transplant patients and effects of islet transplantation. Diabetes Care 30:3063–3069, 2007 PubMed
Quattrini C, Tavakoli M, Jeziorska M, et al.: Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes 56:2148–2154, 2007 PubMed
Mehra S, Tavakoli M, Kallinikos PA, et al.: Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with type 1 diabetes. Diabetes Care 30:2608–2612, 2007 PubMed
Fioretto P, Steffes MW, Sutherland DE, et al.: Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339:69–75, 1998 PubMed
Matricali GA, Bammens B, Kuypers D: High rate of Charcot foot attacks early after simultaneous pancreas-kidney transplantation. Transplantation 83:245–246, 2007 PubMed